1
|
Pucci MJ, Berger AC, Lim PW, Chojnacki KA,
Rosato EL and Palazzo F: Laparoscopic approaches to gastric
gastrointestinal stromal tumors: an institutional review of 57
cases. Surg Endosc. 26:3509–3514. 2012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Ma JJ, Hu WG, Zang L, Lu AG, Wang ML, Li
JW, Feng B, Zhong J and Zheng MH: Laparoscopic gastric resection
approaches for gastrointestinal stromal tumors of stomach. Surg
Laparosc Endosc Percutan Tech. 21:101–105. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Karakousis GC, Singer S, Zheng J, Gonen M,
Coit D, DeMatteo RP and Strong VE: Laparoscopic versus open gastric
resections for primary gastrointestinal stromal tumors (GISTs): a
size-matched comparison. Ann Surg Oncol. 18:1599–1605. 2011.
View Article : Google Scholar
|
4
|
Thakkar DV, Wani SV, Shetty V and Patankar
RV: Laparoscopic sleeve gastrectomy for a large gastrointestinal
stromal tumor. Surg Laparosc Endosc Percutan Tech. 22:e61–e62.
2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Choi H, Charnsangavej C, Faria SC,
Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA and
Benjamin RS: Correlation of computed tomography and positron
emission tomography in patients with metastatic gastrointestinal
stromal tumor treated at a single institution with imatinib
mesylate: proposal of new computed tomography response criteria. J
Clin Oncol. 25:1753–1759. 2007. View Article : Google Scholar
|
6
|
De Vogelaere K, Van Loo I, Peters O,
Hoorens A, Haentjens P and Delvaux G: Laparoscopic resection of
gastric gastrointestinal stromal tumors (GIST) is safe and
effective, irrespective of tumor size. Surg Endosc. 26:2339–2345.
2012.PubMed/NCBI
|
7
|
Takahashi T, Takeuchi H, Kawakubo H,
Saikawa Y, Wada N and Kitagawa Y: Single-incision laparoscopic
surgery for partial gastrectomy in patients with a gastric
submucosal tumor. Am Surg. 78:447–450. 2012.PubMed/NCBI
|
8
|
Hirano Y, Watanabe T, Uchida T, Yoshida S,
Kato H and Hosokawa O: Laparoendoscopic single site partial
resection of the stomach for gastrointestinal stromal tumor. Surg
Laparosc Endosc Percutan Tech. 20:262–264. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Blay JY, Bonvalot S, Casali P, Choi H,
Debiec-Richter M, Dei Tos AP, Emile JF, Gronchi A, Hogendoorn PC,
Joensuu H, Le Cesne A, McClure J, Maurel J, Nupponen N, Ray-Coquard
I, Reichardt P, Sciot R, Stroobants S, van Glabbeke M, van Oosterom
A and Demetri GD; GIST consensus meeting panelists: Consensus
meeting for the management of gastrointestinal stromal tumors.
Report of the GIST Consensus Conference of 20–21 March 2004, under
the auspices of ESMO. Ann Oncol. 16:566–578. 2005.PubMed/NCBI
|
10
|
Spampinato MG, Mandalá L, Quarta G, Del
Medico P and Baldazzi G: One-stage, totally laparoscopic major
hepatectomy and colectomy for colorectal neoplasm with synchronous
liver metastasis: Safety, feasibility and short-term outcome.
Surgery. July 31–2012.(Epub ahead of print).
|
11
|
Heinrich MC, Corless CL, Demetri GD,
Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen CJ, Van den
Abbeele AD, Druker BJ, Kiese B, Eisenberg B, Roberts PJ, Singer S,
Fletcher CD, Silberman S, Dimitrijevic S and Fletcher JA: Kinase
mutations and imatinib response in patients with metastatic
gastrointestinal stromal tumor. J Clin Oncol. 21:4342–4349. 2003.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Heinrich MC, Owzar K, Corless CL, Hollis
D, Borden EC, Fletcher CD, Ryan CW, von Mehren M, Blanke CD, Rankin
C, Benjamin RS, Bramwell VH, Demetri GD, Bertagnolli MM and
Fletcher JA: Correlation of kinase genotype and clinical outcome in
the North American Intergroup Phase III Trial of imatinib mesylate
for treatment of advanced gastrointestinal stromal tumor: CALGB
150105 study by Cancer and Leukemia Group B and Southwest Oncology
Group. J Clin Oncol. 26:5360–5367. 2008.
|